Debashree Mukherjea

Department of Surgery, Southern Illinois University School of Medicine

Affiliated withSouthern Illinois University School of Medicine

Research Area

Biography

Debashree Mukherjea has not added Biography.
If you are Debashree Mukherjea and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 12	2018

Other Publications

Article	Year
Expression and function of placenta growth factor: implications for abnormal placentation. Journal of the Society for Gynecologic Investigation\| PubMed ID: 12759145	2003
Essential role of Rac1/NADPH oxidase in nerve growth factor induction of TRPV1 expression. Journal of neurochemistry\| PubMed ID: 16283857	2005
Induction of adenosine A1 receptor expression by pertussis toxin via an adenosine 5'-diphosphate ribosylation-independent pathway. The Journal of pharmacology and experimental therapeutics\| PubMed ID: 16322354	2006
Activation of the adenosine A1 receptor inhibits HIV-1 tat-induced apoptosis by reducing nuclear factor-kappaB activation and inducible nitric-oxide synthase. Molecular pharmacology\| PubMed ID: 17609415	2007
Glial cell missing 1 regulates placental growth factor (PGF) gene transcription in human trophoblast. Biology of reproduction\| PubMed ID: 18160678	2008
Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatin-induced hearing loss in the rat. The Journal of neuroscience : the official journal of the Society for Neuroscience\| PubMed ID: 19052196	2008
Role of beta-arrestin1/ERK MAP kinase pathway in regulating adenosine A1 receptor desensitization and recovery. American journal of physiology. Cell physiology\| PubMed ID: 19828838	2010
Cisplatin ototoxicity and protection: clinical and experimental studies. The Tohoku journal of experimental medicine\| PubMed ID: 19851045	2009
Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity. Neoplasia (New York, N.Y.)\| PubMed ID: 19881949	2009
Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat. Antioxidants & redox signaling\| PubMed ID: 20214492	2010
Pharmacogenomics of cisplatin-induced ototoxicity. Pharmacogenomics\| PubMed ID: 21787192	2011
The design and screening of drugs to prevent acquired sensorineural hearing loss. Expert opinion on drug discovery\| PubMed ID: 22646075	2011
Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway. PloS one\| PubMed ID: 23272133	2012
Essential Role of NADPH Oxidase-Dependent Reactive Oxygen Species Generation in Regulating MicroRNA-21 Expression and Function in Prostate Cancer. Antioxidants & redox signaling\| PubMed ID: 23682737	2013
Adenosine receptors: expression, function and regulation. International journal of molecular sciences\| PubMed ID: 24477263	2014
TRPV1: A Potential Drug Target for Treating Various Diseases. Cells\| PubMed ID: 24861977	2014
Early investigational drugs for hearing loss. Expert opinion on investigational drugs\| PubMed ID: 25243609	2015
Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea. The Journal of neuroscience : the official journal of the Society for Neuroscience\| PubMed ID: 27053204	2016
Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: Reversal by resveratrol. PloS one\| PubMed ID: 28467474	2017
Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity. Cell death & disease\| PubMed ID: 28703809	2017
Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection. Frontiers in cellular neuroscience\| PubMed ID: 29163050	2017